28
Participants
Start Date
April 1, 2024
Primary Completion Date
May 1, 2024
Study Completion Date
May 1, 2024
SY-5007
SY-5007 160 mg, Tablets, 2 discrete single doses separated by 7-days
SY-5007
SY-5007 160 mg, Tablets, 2 discrete single doses separated by 7-days
West China Hospital of Sichuan University, Chengdu
Shouyao Holdings (Beijing) Co. LTD
OTHER